Leading researchers praise the field’s many successes—but remind us the war on AIDS is far from over
On the heels of the premature termination of a Phase IIb HIV vaccine trial in the US known as HVTN 505 comes fresh scrutiny of an earlier Phase IIb study from South Africa that was halted a few months after it started in 2007
Could recent breakthroughs in research be applied to make broadly effective vaccines against HIV?
International AIDS Vaccine Initiative. All rights reserved.